Canada Gene Synthesis Market

Canada Gene Synthesis Market Size Insights Forecasts to 2035

• The Canada Gene Synthesis Market Size was estimated at USD 60.56 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 14.18% from 2025 to 2035
• The Canada Gene Synthesis Market Size is Expected to Reach USD 260.34 Million by 2035

According to a Research Report Published by Decisions Advisors & Consulting, The Canada Gene Synthesis Market Size is anticipated to Reach USD 260.34 Million by 2035, Growing at a CAGR of 14.18% from 2025 to 2035. Among the major factors driving the gene synthesis market share are the growing prevalence of different genetic disorders, the growing demand for gene therapies and personalised medicine, and the rise in disposable income levels.

Market Overview

The design, chemical synthesis, and commercialisation of synthetic DNA sequences for research, diagnostics, and therapeutic development constitute the Canadian gene synthesis market, a subset of the country's biotechnology and life sciences sector. This term is referred to as transforming synthetic biology, genetic engineering, and molecular biology by laying the groundwork for the creation of unique genes that were previously impractical or impossible to produce. It has numerous uses in industrial biotechnology, healthcare, and agriculture, facilitating the development of novel biomaterials, genetically modified crops, and gene-based therapies. The field of synthetic biology, which focuses on creating new biological systems or redesigning old ones, is also developing thanks in large part to gene synthesis. This method can be used to synthesise large amounts of DNA from scratch, alter already existing genes, or create entirely new genes. Additionally, there are many uses for gene synthesis in biotechnology, research, medicine, and other domains where genetic engineering is necessary. Further, the of launched the $200 million Canadian Precision Health Initiative (CPHI), aiming to build the country’s largest-ever human genomic dataset to transform healthcare and fuel economic growth. This landmark initiative, announced in March 2025, is promoted by Genome Canada with support from regional genome centres and multiple public-private partners.

Report Coverage

This research report categorises the market for the Canada gene synthesis market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada Gene Synthesis market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada Gene Synthesis market.

Driving Factors

The robust biotechnology industry with sophisticated research infrastructure in Canada encourages innovation and the high demand for synthetic genes in therapeutic and research applications, which in turn propels the country's gene synthesis market. Further, local market expansion is being accelerated by rising public and private sector investments in synthetic biology and genomics. Moreover, the growing demand is being greatly increased by the increase in drug development and discovery, as well as the application of gene synthesis in personalised medicine. Gene synthesis technologies are supported by Canada's supportive regulatory framework and government programs, including significant R&D funding from organisations like the National Research Council of Canada.

Restraining Factors

Despite substantial growth Canadian gene synthesis market faces several obstacles, such as, high expense of sophisticated gene synthesis technologies and the difficulty of creating lengthy, precise DNA sequences, particularly for startups and smaller research institutions. Moreover, delays and higher compliance costs may result from regulatory issues with synthetic biology, biosecurity, and intellectual property rights.

Market Segmentation

The Canada gene synthesis market share is classified into method and type.

• The PCR-based enzyme synthesis segment held a substantial share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

The Canada gene synthesis market is segmented by method into solid-phase synthesis, chip-based synthesis, and PCR-based enzyme synthesis. Among these, the PCR-based enzyme synthesis segment held a substantial share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is driven by 2030 due to a number of factors, including its accuracy, usability, and affordable technology. Furthermore, when the gene encoding the protein is hard or impossible to express efficiently, PCR-based gene synthesis offers a straightforward solution to the problem of generating sizable amounts of labelled protein for NMR spectroscopy.

• The gene and cell therapy development segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Canada gene synthesis market is segmented by type into gene and cell therapy development, vaccine development, disease diagnosis, and others. Among these, the gene and cell therapy development segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the increasing number of advanced therapies available for the treatment of chronic illnesses. Further, due to their effectiveness in treating illnesses that were previously incurable with conventional treatment methods, these therapies are becoming increasingly popular among therapy developers. Further, advanced cell and gene therapy treatments, biotechnology and pharmaceutical companies have launched several initiatives.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the Canada gene synthesis market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Bio Basic Inc.
• Deep Genomics
• GenScript Canada
• Integrated DNA Technologies (IDT)
• SynBridge (U of Lethbridge)
• Genome Canada Partners
• Others

Recent Developments:

• In March 2025, Integrated DNA Technologies (IDT) and Elegen formed a strategic partnership to revolutionise the long DNA synthesis market, launching an early access program for high-complexity genes up to 15 kb. A cost-effective solution for NGS-verified 5 kb to 15 kb clonal genes, shipped from Elegen's U.S. facility in as little as 10 business days, made available to IDT early access customers for the first time thanks to this partnership.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Canada, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the Canada Gene Synthesis Market based on the below-mentioned segments:

Canada Gene Synthesis Market, By Method

• Solid-phase Synthesis
• Chip-based Synthesis
• PCR-based Enzyme Synthesis

Canada Gene Synthesis Market, By Application

• Gene and Cell Therapy Development
• Vaccine Development
• Disease Diagnosis
• Others